JESSE MYERS: Open Payments
NPI 1275788457 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 36 payments from 12 companies in 2025. Trend: 2023 $1,422 · 2024 $2,280 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $374 |
| PFIZER INC. | 5 | $125 |
| Aimmune Therapeutics, Inc. | 6 | $117 |
| Janssen Biotech, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Madrigal Pharmaceuticals | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Intra-Sana Laboratories | 1 | $50 |
| ABBVIE INC. | 2 | $47 |
| VIVUS LLC | 2 | $42 |
Products named: DUPIXENT, ZENPEP, TREMFYA, ENTYVIO, VELSIPITY, REZDIFFRA, RELTONE 200 MG, CREON.
Industry payments across CA — which companies pay providers there.
